Friday, December 2, 2022

Markets

Resilience, innovation and ambition: the capital market and companies

Pedro Wilton, Senior Account Manager, Euronext Lisbon

TechShare program with 10 portuguese companies

What opportunities may the capital market offer to technology companies and how can they prepare for an eventual IPO? Providing answers to these questions and supporting entrepreneurs to become familiar with the capital market is the main objective of Euronex’s TechShare program, launched in 2015. The 6th edition of this program, which started in October 2020 and should run until June 2021, comprises innovative companies from eight countries: Germany, Belgium, Spain, France, Holland, Italy, Portugal and Switzerland.

The program that prepares technological companies for the stock market

The 5th edition of Euronext’s TechShare, which started in September 2019, runs until May this year. This pan-European program aims at informing tech companies about the opportunities offered by capital markets and how they can prepare for an eventual...

Artigos recentes | Recent articles

The designer who conquered the world

Interview with Nini Andrade Silva
É conhecida como a ‘designer’ de interiores da Madeira, mas Nini Andrade silva gosta de tudo o que tem a ver com a arte e com o processo de criar. Já perdeu a conta aos prémios, nacionais e internacionais, que recebeu com as largas centenas de hotéis que desenhou nos mais variados pontos do mundo. E afirma que o seu ‘hobbie’ é trabalhar.

Strengthening Civil Society and its Capacity to Improve Quality of Life in Mozambique

Sarah James Founded on the ethics and values that drive inclusive progress and positive change, civil society institutions – from education and healthcare, to the...

“Without the private effort, the Portuguese State would not have been able to face the pandemic”

In an interview with PRÉMIO, Germano de Sousa, clinical pathologist and president of the josé Germano de Sousa Laboratory Medicine Centre, spoke about his career as a doctor, his former position as President of the Portuguese Doctors Association and the growth of his network of laboratories, operating in the field of clinical pathology laboratory trials and the main national player in this sector, currently performing 15 to 16% of Covid tests in Portugal.
- Advertisement -